Clinical & Experimental Immunology
© British Society for Immunology

Edited By: M. Peakman
Impact Factor: 3.134
ISI Journal Citation Reports © Ranking: 2010: 56/134 (Immunology)
Online ISSN: 1365-2249
Recently Published Issues
Current Issue:June 2012
Volume 168, Issue 3
Volume 168, Issue 2
Volume 168, Issue 1
Volume 167, Issue 3
Volume 167, Issue 2
CEI: Top 20
Free-to-Access: CEI's top 20 downloaded articles in 2011
The ‘hygiene hypothesis’ for autoimmune and allergic diseases: an update
H. Okada, C. Kuhn, H. Feillet, J.-F. Bach
An approach to the diagnosis and management of systemic vasculitis
A. Miller, M. Chan, A. Wiik, S. A. Misbah and R. A. Luqmani
Isolation and preservation of peripheral blood mononuclear cells for analysis of islet antigen-reactive T cell responses: position statement of the T-Cell Workshop Committee of the Immunology of Diabetes Society
R. Mallone, S. I Mannering, B. M. Brooks-Worrell, I. Durinovic-Belló, C. M. Cilio, F. S. Wong and N. C. Schloot, on behalf of the Immunology of Diabetes Society T-Cell Workshop Committee
Nomenclature and classification of vasculitis – update on the ACR/EULAR Diagnosis and Classification of Vasculitis Study (DCVAS)
J. C. Jennette
Nomenclature and classification of vasculitis: lessons learned from granulomatosis with polyangiitis (Wegener's granulomatosis)
R. A. Luqmani, R. Suppiah, P. C. Grayson, P. A. Merkel and R. Watts
News
2010 Impact Factor: CEI on the rise again!
With the publication of the 2010 impact factors, Wiley-Blackwell and the British Society for Immunology are delighted to announce that CEI has risen again this year to 3.134.
Disclosure
We encourage authors to declare potential conflicts of interest, in order to allow the journal readership to make a balanced appraisal of the author(s) interests. Details are available in the Author Guidelines.
NIH Public Access Mandate
For those interested in the Wiley-Blackwell policy on the NIH Public Access Mandate, please visit this information page.
Key Reviews from CEI
Click on the links below for FREE access to CEI Review collections:
Plus:
About CEI
- Submission to First Decision: 19 days
- Submission to Final Decision: 52 days
Authors should please note that we have recently updated the journal’s ethical policies and information can be found here.
Clinical & Experimental Immunology is a top ranking, international journal publishing biologically significant studies that have clinical relevance. Providing an international forum for the publication of original research on all aspects of clinical immunology and translational immunology, Clinical & Experimental Immunology is amongst the foremost journals in this field, attracting high-quality papers from all parts of the world. Translation is viewed as a process of applying ideas, insights and discoveries generated through basic scientific studies to the treatment, prevention or diagnosis of human disease.
Clinical & Experimental Immunology presents clinical immunological studies covering: immunopathogenesis of communicable and parasitic diseases; rheumatic, renal and endocrine disorders; immunological disorders in other organ systems and malignancy and transplantation.
All CEI review articles are free-to-access from point of publication, and all journal content is free-to-access after a period of 12 months.
British Society for Immunology members enjoy free online access to the journal. Find out how to join the society here.
Bite-Sized Immunology
Bite-Sized Immunology is a developing online resource, with downloadable content, designed to form a comprehensive guide to the the immune system.

1365-2249/asset/cei_left.gif?v=1&s=ffee144c532fe5e73bbb89290ba14e154b0d400b)
1365-2249/asset/cei_right.gif?v=1&s=c14d545a5215173707c8202758d5b25fd0bede44)
1365-2249/asset/homepages/bite-sized-click.jpg?v=1&s=6c9acfb3af0054ae1c2c1c94c27da5ba086f38fb)
1365-2249/asset/society_affiliation_image.gif?v=1&s=db0fbe0646bffa9fa5b17daf8dc3329fb71b2450)